George Frangeskides, Chairman at ALBA, explains why the Pilbara Lithium option ‘was too good to miss’. Watch the video here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHONY.L Regulatory News (HONY)

  • There is currently no data for HONY

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

NAV and Monthly Update - November 2020

7 Jan 2021 07:00

RNS Number : 8355K
Honeycomb Investment Trust PLC
07 January 2021
 

NOT FOR PUBLICATION, DISTRIBUTION OR RELEASE, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, ANY MEMBER STATE OF THE EUROPEAN ECONOMIC AREA (OTHER THAN THE UNITED KINGDOM), CANADA, AUSTRALIA, THE REPUBLIC OF SOUTH AFRICA OR JAPAN OR ANY OTHER JURISDICTION IN WHICH THE DISTRIBUTION OR RELEASE WOULD BE UNLAWFUL

7 January 2021

Honeycomb Investment Trust plc

Honeycomb Investment Trust plc (the "Company") announces that the Investment Manager's monthly factsheet for 30 November 2020 is now available on its website at http://www.honeycombplc.com.

Net Asset Value per Share

The Company announces that its unaudited Net Asset Value ("NAV") per share as at 30 November 2020 on a cum-income basis was 1,006.4 pence, based on a NAV of £354.9 million, and on an ex-income basis was 1,017.9 pence, based on a NAV of £358.9 million. The NAVs have been calculated by Apex Fund Services (UK) Ltd.

November Factsheet

Honeycomb Investment Trust plc (the "Company") delivered a NAV return of 0.62% for the month, which is equivalent to 7.5% per annum. The portfolio continues to perform well with NAV returns rising to pre-Covid-19 levels.

 

The Manager deployed £30m of investment into Credit Assets over the course of November including the acquisition of a portfolio of performing short term real estate loans. This increased the investment portfolio to £576.9m.

The larger investment portfolio has increased returns with NAV return for November at 7.5% per annum. The investment yield was 9.7% per annum with a modest impairment charge of 0.3% per annum. The low impairment charge reflects the increasing proportion of structurally secured loans, which given the seniority, generally have lower impairments and the low levels of new forbearance requests. Third party servicing costs remain at 0.6% per annum. This is expected to reduce over time as the Company reduces its exposure to consumer direct and reduces the corresponding service charge.

Buybacks

 

In November the Company repurchased 210,000 of its shares at an average price of 922.7p. The total buybacks year to date now total 4,190,178 or 10.6% of the share capital. The Company has reduced the level of buybacks recently as the share price has performed well.

 

 

 

 

This document is made available for information purposes only and does not contain any representations or constitute an offer to sell or the solicitation of an offer to acquire or subscribe for any securities of the Company. All investments are subject to risk. Prospective investors are advised to seek expert legal, financial, tax and other professional advice before making any investment decision. The value of investments may fluctuate and past performance is no guarantee of future results. 

For further information about this announcement please contact:

Pollen Street Capital - Investment Manager

Matthew Potter / Julian Dale: +44 (0)20 3728 6750

Liberum Capital Limited - Joint Broker

Chris Clarke / Louis Davies: +44 (0)20 3100 2000 

Cenkos Securities plc - Joint Broker

Justin Zawoda-Martin / Rob Naylor: +44 (0)20 7397 8900

Link Company Matters Limited - Corporate Secretary

Paul Johnston: +44 (0)20 7954 9552

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NAVGZGGMNVNGMZM
Date   Source Headline
12th Aug 20202:11 pmRNSForm 8.3 - [Honeycomb Investment Trust Plc]
12th Aug 20201:30 pmRNSForm 8.3 - Honeycomb Investment Trust Plc
12th Aug 20209:09 amRNSForm 8.5 (EPT/RI)
11th Aug 202011:51 amGNWForm 8 (OPD) [Honeycomb Investment Trust plc] - (HHL)
11th Aug 20209:56 amRNSForm 8.5 (EPT/RI)
10th Aug 20202:50 pmRNSForm 8.5 (EPT/RI)
10th Aug 20202:23 pmRNSShare Buy-Back Programme
10th Aug 20201:09 pmRNSForm 8.3 - Honeycomb Investment Trust PLC
10th Aug 202012:51 pmGNWForm 8.3 - AXA INVESTMENT MANAGERS: Honeycomb Investment Trust plc
10th Aug 20209:57 amRNSForm 8.5 (EPT/RI)
7th Aug 20201:36 pmRNSForm 8.3 - Honeycomb Investment Trust plc
6th Aug 20206:24 pmRNSPossible offer for Pollen Street Secured Lending
3rd Aug 20207:01 amRNSMonthly Update - June 2020
3rd Aug 20207:00 amRNSNet Asset Value(s)
26th Jun 20205:41 pmRNSResult of AGM
25th Jun 20207:01 amRNSMonthly Update - May 2020
25th Jun 20207:00 amRNSNet Asset Value(s)
4th Jun 20201:41 pmRNSDirector/PDMR Shareholding
4th Jun 202011:21 amRNSHolding(s) in Company
3rd Jun 20204:39 pmRNSPosting of Annual Report and Notice of AGM
3rd Jun 20207:00 amRNSResult of Buyback and Total Voting Rights
2nd Jun 20204:30 pmRNSShare Buy-Back
28th May 20207:01 amRNSMonthly Update - April 2020
28th May 20207:00 amRNSNet Asset Value(s)
28th May 20207:00 amRNSDividend Declaration
28th May 20207:00 amRNSAnnual Report and Audited Financial Statements
4th May 20201:06 pmRNSDirector/PDMR Shareholding
1st May 20207:01 amRNSMonthly Update - March 2020
1st May 20207:00 amRNSNet Asset Value(s)
26th Mar 20207:01 amRNSMonthly Update - February 2020
26th Mar 20207:00 amRNSNet Asset Value(s)
5th Mar 20205:08 pmRNSHolding(s) in Company
5th Mar 20204:34 pmRNSHolding(s) in Company
2nd Mar 20209:12 amRNSRelationship with Pollen Street Capital
2nd Mar 20207:01 amRNSMonthly Update - January 2020
2nd Mar 20207:00 amRNSNet Asset Value(s)
25th Feb 202012:02 pmRNSHolding(s) in Company
25th Feb 202010:31 amRNSHolding(s) in Company
24th Feb 20201:15 pmRNSHolding(s) in Company
24th Feb 202011:31 amRNSHolding(s) in Company
21st Feb 20204:38 pmRNSResult of Share Sale
21st Feb 20204:31 pmRNSHolding(s) in Company
21st Feb 20202:32 pmRNSProposed Share Sale
19th Feb 20203:15 pmRNSHolding(s) in Company
19th Feb 20207:00 amRNSDividend Declaration
31st Jan 202010:02 amRNSHolding(s) in Company
30th Jan 202012:30 pmRNSHolding(s) in Company
29th Jan 20202:27 pmRNSHolding(s) in Company
29th Jan 20202:10 pmRNSHolding(s) in Company
28th Jan 20205:42 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.